Your Brain's Chemical Messengers: A Guide to Neurotransmitters

In a quiet pharmacology laboratory at the University of Lund, Sweden, sometime around 1957, a researcher named Arvid Carlsson was watching rabbits. The animals had been given reserpine, a drug that left them rigid and nearly motionless, slumped where they sat. Then Carlsson dosed them with a compound called L-DOPA, and within a short while the rabbits stirred, lifted their heads, and began to move again. To most observers it might have looked like a minor curiosity of animal pharmacology. To Carlsson, it was evidence for a radical idea: that a small molecule called dopamine, until then dismissed as a mere stepping stone in the body's chemistry, was actually a messenger the brain used to talk to itself.

That observation helped redraw the entire chemical map of the brain, and decades later it earned Carlsson a share of the 2000 Nobel Prize in Physiology or Medicine. But it was only one episode in a much longer detective story, stretching across most of the twentieth century, in which biologists worked out how billions of neurons coordinate everything we feel, remember, and do. The answer turned out to be surprisingly orderly. Rather than a chaotic chemical soup, the brain runs largely on a handful of well-defined signaling systems. This article walks through those systems, what each one does, and how we came to know them.

How One Neuron Speaks to the Next

A neuron is an electrical cell, but the gap between one neuron and the next, the synapse, is a chemical bridge. When an electrical signal reaches the end of a neuron, it triggers the release of a chemical messenger called a neurotransmitter into that gap. The molecule drifts across, binds to receptor proteins on the receiving cell, and either nudges that cell toward firing its own signal or holds it back. Then the message has to be cleared away quickly so the synapse is ready for the next pulse.

Receptors come in two broad flavors, and the distinction matters for understanding what follows. Ionotropic receptors are themselves channels: when the neurotransmitter binds, a pore opens and ions rush through, producing a fast and brief effect measured in thousandths of a second. Metabotropic receptors work more slowly and indirectly, setting off a chain of chemical reactions inside the receiving cell that can shape its behavior for longer. Most neurotransmitters act on a mix of both kinds, which is part of why a single molecule can have such varied effects depending on where in the brain it is working and which receptors are present.

The proof that synapses are chemical at all came from a famous experiment we will return to shortly. For now, the key point is that this chemical handoff is the fundamental operation the brain repeats trillions of times a second, and the whole vocabulary of that handoff comes down to a small number of molecules.

Glutamate and GABA, the Brain's Accelerator and Brake

If you want to understand the brain's everyday electrical traffic, start with two molecules that do most of the heavy lifting. The first is glutamate, the brain's main excitatory neurotransmitter. Glutamate is the accelerator: when it binds to a receiving neuron, it pushes that cell toward firing. It carries roughly 80 percent of fast excitatory transmission in the cortex and hippocampus, the regions central to perception, thought, and memory. Glutamate acts on ionotropic receptors known as AMPA and NMDA receptors, which open ion channels directly, and on a family of metabotropic receptors labeled mGluR1 through mGluR8. Because glutamate is so abundant and so excitatory, the brain has to mop it up efficiently, and specialized support cells called astrocytes carry transporters that pull it out of the synaptic cleft.

The natural counterpart is GABA, short for gamma-aminobutyric acid, the brain's main inhibitory neurotransmitter. If glutamate is the accelerator, GABA is the brake: it quiets neurons and keeps activity from running away into uncontrolled excitation. GABA is used at roughly 20 percent of cortical synapses, largely by specialized inhibitory neurons such as parvalbumin and somatostatin interneurons that keep local circuits in check. There is a neat chemical relationship between the two molecules, because GABA is synthesized directly from glutamate by an enzyme called glutamic acid decarboxylase. In effect, the brain takes its primary excitatory transmitter and converts a portion of it into its primary inhibitory one. GABA acts on GABA-A receptors, which are ionotropic chloride channels, and on slower metabotropic GABA-B receptors.

Together these two define the brain's basic electrical balance. Excitation and inhibition have to be held in careful equilibrium, and many disorders, from epilepsy to anxiety, can be understood partly in terms of that balance tipping one way or the other.

The Four Modulators That Tune the Whole Brain

Glutamate and GABA do the fast point-to-point signaling, but four other systems work differently. These are the modulatory monoamines: acetylcholine, dopamine, serotonin, and norepinephrine. Rather than simply turning neurons on or off, they tune the brain's overall state, adjusting attention, motor control, reward, mood, and arousal. They behave less like a wire carrying a single message and more like a dimmer switch or a volume knob applied to whole regions at once.

What is remarkable is how few neurons are involved. Each of these systems originates in a small, specialized cluster of cells deep in the brain, and from those tiny origins their fibers fan out across nearly the entire cortex. Dopamine comes mainly from two midbrain regions, the substantia nigra and the ventral tegmental area. Serotonin arises in the raphe nuclei of the brainstem. Norepinephrine comes from a structure in the pons called the locus coeruleus. And the acetylcholine that reaches the cortex comes largely from a basal forebrain region called the nucleus basalis of Meynert. A few thousand cells in each case end up shaping the activity of billions. This architecture, a small source broadcasting widely, is exactly what you would design if you wanted a handful of signals to set the mood and readiness of the whole system.

Acetylcholine and the First Glimpse of Brain Chemistry

The story of these systems properly begins with acetylcholine, the first chemical neurotransmitter ever identified. In 1921, a pharmacologist named Otto Loewi performed an experiment in Graz, Austria, that he claimed had come to him in a dream. He kept two frog hearts alive in separate baths, one still attached to its vagus nerve. When he stimulated that nerve, the heart slowed, and the fluid bathing it now slowed the second heart too when transferred over. Something chemical had been released by the nerve. Loewi called the unknown substance Vagusstoff, German for "vagus substance," and it was later identified as acetylcholine. That single experiment proved that nerves communicate chemically, not just electrically, and it laid the foundation for everything that followed.

In the brain, acetylcholine runs two major central systems. One projects from the nucleus basalis of Meynert to the cortex and is central to attention. The other, a pontomesencephalic system, projects to the thalamus and cortex and is bound up with arousal and the dreaming state of REM sleep. Beyond the brain, acetylcholine does decidedly physical work: it is the molecule that nerves use to command muscles at the neuromuscular junction, and it carries signals through the autonomic ganglia that regulate the body's internal organs. The same messenger that helps you concentrate also tells your biceps to contract.

Dopamine, Serotonin, and Norepinephrine, the Great Broadcasters

This brings us back to Carlsson's rabbits. For years dopamine had been treated as nothing more than a chemical intermediate, a way station on the path to making other molecules. Carlsson's demonstration in the late 1950s, that reserpine-induced rigidity could be reversed by the dopamine precursor L-DOPA, established dopamine as a neurotransmitter in its own right. The medical payoff arrived quickly. Recognizing that the rigidity of his rabbits resembled the symptoms of Parkinson disease, researchers connected the dots, and in 1961 Birkmayer and Hornykiewicz translated the insight into L-DOPA therapy for Parkinson patients, a treatment still in use today. Dopamine's projections from the substantia nigra and ventral tegmental area drive both fine motor control and the brain's reward signals, which is why its disruption shows up in conditions as different as Parkinson disease and addiction.

The other two broadcasters cast their nets even more widely. Serotonin originates in the raphe nuclei of the brainstem and projects almost everywhere: cortex, limbic system, thalamus, hypothalamus, and down into the spinal cord. It is associated with mood and a broad range of regulatory functions, which helps explain why drugs affecting serotonin are central to treating depression. Norepinephrine comes from the locus coeruleus, a structure containing only about 1,500 neurons per side, yet this tiny nucleus is the brain's primary noradrenergic source and projects throughout the entire cortical mantle, where it governs arousal and alertness. The economy of the design is striking: a cluster you could lose in a grain of rice sets the wakefulness of the whole forebrain.

Eighty Years to Map the Chemistry

It is worth pausing on how long this picture took to assemble, because it is a reminder that even our most basic understanding of the brain is recent and hard-won. The chemistry came together over roughly eight decades. Loewi proved chemical transmission in 1921. In 1952, the physiologist Bernard Katz quantified how neurotransmitters are actually released, showing that they come out in discrete packets rather than a smooth stream. Carlsson rescued dopamine from obscurity in the late 1950s, and Birkmayer and Hornykiewicz turned that finding into a real therapy by 1961. The arc reached a symbolic close in 2000, when Carlsson shared the Nobel Prize with Paul Greengard and Eric Kandel for work that illuminated how these chemical signals underlie movement, reward, and the cellular basis of memory itself.

A few numbers fix the scale of these systems and are worth keeping in mind. Glutamate operates at roughly 80 percent of cortical synapses and GABA at about 20 percent. The locus coeruleus holds around 1,500 noradrenergic neurons per side, while the substantia nigra contains on the order of 400,000 dopamine neurons per side at birth. And one figure tends to surprise people: although serotonin is famous as a brain chemical, roughly 90 percent of the body's serotonin is actually found in the gut, where it helps regulate digestion. The brain's signaling molecules, it turns out, rarely stay confined to the brain.

Key Takeaways

The brain runs not on chaos but on a handful of well-defined chemical systems, and understanding them gives you a working map of how neurons coordinate everything you do. Two workhorses dominate fast signaling, with glutamate as the main excitatory transmitter carrying about 80 percent of cortical excitation through AMPA, NMDA, and metabotropic receptors, and GABA, synthesized from glutamate by glutamic acid decarboxylase, providing the inhibition at roughly 20 percent of synapses that keeps activity in balance. Layered on top are four modulatory monoamines that broadcast from tiny deep-brain nuclei across the whole cortex: acetylcholine, the first transmitter identified through Otto Loewi's 1921 frog-heart experiment, governing attention and muscle control; dopamine, established as a true transmitter by Arvid Carlsson in the late 1950s and central to movement and reward, with its discovery leading to L-DOPA therapy for Parkinson disease in 1961; serotonin, rising from the raphe nuclei to shape mood and regulation though mostly resident in the gut; and norepinephrine, broadcast from the roughly 1,500 neurons of the locus coeruleus to set arousal. Built up patiently between Loewi's experiment in 1921 and the 2000 Nobel Prize shared by Carlsson, Greengard, and Kandel, this six-system framework remains the foundation for understanding how the brain works and how the drugs that treat its disorders do their job.